LIBROS
Holder LE, Fogelman I, CollierD, eds. An atlas of planar and SPECT bone scans (2.nded.). London: Martin Dunitz, 1999.
Wayne Meikle A, ed. Hormonereplacement therapy. Totowa: Humana Press, 1999.
NÚMEROSMONOGRÁFICOS
Kurokama K, Fukagawa M, eds.Renal osteodystrophy Symposium: Calcium metabolism in health anduremia. Am J Clin Sci 1999; 315: 355-417.
NUESTROSAUTORES
Hawkins F, Jodar E.Osteoporosis posmenopáusica: aspectos nutricionales.Formación Continuada en Nutrición y Obesidad 1999; 2:305-315.
Martínez MA,López G. Prevención cardiovascular y de laosteoporosis con terapia hormonal sustitutiva. Rev Med Univ Navarra1999; 43: 34-43.
González JM,Martínez MJ, Miñarro A, et al. Hipovitaminosis D:alta prevalencia en ancianos de Barcelona atendidosambulatoriamente. Factores asociados. Med Clin (Barc) 1999; 113:641-645.
González DC, MautalenCA. Short-term therapy with oral olpadronate in active Paget'sdisease of bone. J Bone Miner Res 1999; 14: 2.942-2.047.
Calbet JAL, Díaz P,Rodriguez LP. High bone mineral density in male elite professionalvolleyball players. Osteoporosis Int 1999; 10: 468-474.
Cannata J. Renal osteodystrophyin Iberoamerica. Am J Kidney Dis 1999; 34: 58-60.
Olmos JM, de Vega Y, Perera ,et al. Etidronate inhibits the production of IL-6 byosteoblast-like cells. Methods Find Exp Clin Pharmacol 1999; 21:519-522.
Guardiola J, Xiol X, Sallie R,et al. Influence of the vitamin D receptor gene polymorphism onbone loss in liver transplantattion. An Int Med 1999; 131:752-755.
Palacios S. Osteoporosis:prevention with estrogens in women over 60. Maturitas 1999; 33:1-6.
Se ruega a los autoresenviar una copia del trabajo para incluir su cita en estasección.
REVISIONES
Frost HM. Changing views about«osteoporoses» (a 1998 overview). Osteoporosis Int1999; 10: 345-352.
Heymann D, Passuti N. Bonesubstitutes: new concepts. Eur J Orttop Surg Traumatol 1999; 9:179-184.
Boyan BD, Sylvia VL, Dean DD,et al. Understanding the bone/implant interface. Osteologie 1999;3: 123-133.
Wilkin TJ, Changing perceptionsin osteoporosis. Br Med J 1999; 318: 862-865.
McEwen BS, Alves SE. Estrogenactions in the central nervous system. Endocrine Rev 1999; 20:279-307.
Malloy PJ, Pike JW, Feldman D.The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin-D-resistant rickets. Endocrine Rev 1999; 2:156-188.
Cassidy JT. Osteopenia andosteoporosis in children. Clin Exp Rheumatol 1999; 17:245-250.
Weaver CM, Peacock M, JohnstonCC. Adolescent nutrition in the prevention of postmenopausalosteoporosis. J Clin Endocrinol Metab 1999; 84:1.839-1.843.
Harper J, Klagsbrun M.Cartilage to bone - angiogenesis leads the way. Nature Med 1999; 5:617-618.
Beckerman P, Silver J. VitaminD and the parathyroid. Am J Med Sci 1999; 317: 363-369.
Suda T, Takahashi N, Udagawa N,et al. Modulation of osteoclast differentiation and function by thenew members of the tumor necrosis factor receptor and ligandsfamily. Endocrine Rev 1999; 20: 345-357.
Miller PD, Zapalowski C, KulakCAM, Bilezikian JP. Bone densitometry: the best way to detectosteoporosis and to monitor therapy. J Clin Endocrinol Metab 1999;84: 1.867-1.871.
Cowin SC. Bone poroelasticity.J Biomech 1999; 32: 217-238.
Walsh BW. The individualizedapproach to menopause management. J Clin Endocrinol Metab 1999; 84:1,900-1.904.
van Duijin. Hormone replacementtherapy and Alzheimer's disease. Maturitas 1999; 31:201-205.
Davis SR. Androgen treatment inwomen. MJA 1999; 170: 545-549.
Cooper DM. Exercise, growth andthe GH-IGF-I axis in children and adolescents. Curr Opin EndocrinolDiabetes 1999; 6: 106-111.
Santoro NF, Col NF, Eckman MH,et al. Hormone replacement therapy-where are we going? J ClinEndocrinol Metab 1999; 84: 1.798-1.812.
Pinkerton JV, Santen R.Alternatives to the use of estrogen in postmenopausal women.Endocrine Rev 1999; 20: 308-320.
Hock JM. Stemming bone loss bysuppressing apoptosis. J Clin Invest 1999; 104: 371-373.
Miller WL, Portale AA. Geneticdisorders of vitamin D biosynthesis. Endocrinol Metab Clin North Am1999; 28: 825-840.
Feldman D. Vitamin D,parathyroid hormone and calcium: a complex regulatory network. Am JMed 1999; 107: 637-639.
Brown A, Dusso A, SlatopolskyE. Vitamin D. Am J Physiol 1999; 277 (2 Pt 2):F157-F175.
Malloy PJ, Feldman D. Vitamin Dresistance. Am J Med 1999; 106: 355-370.
Marsh DR, Li G. The biology offracture healing: optimizing outcome. Brit Med Bull 1999; 55:856-869.
Prockop DJ. Genetic trail ofosteoporosis: candidate genes versus genoma screens? Small familiesversus large families? J Bone Miner Res 1999; 14:2.000-2.001.
Kaste SC, Chesney RW, HudsonMM, et al. Bone mineral status during and after therapy ofchildhood cancer: an increasing population with multiple riskfactors for impaired bone health. J Bone Miner Res 1999; 14:2.010-2.001.
Kaste SC, Chesney RW, HudsonMM, et al. Bone mineral status during and after therapy ofchildhood cancer: an increasing population with multiple riskfactors for impaired bone health. J Bone Miner Res 1999; 14:2.010-2.014.
Pfeifer M, Minne HW. Vitamin Dand hip fracture. Trends Endocrinol Metab 1999; 10:417-420.
Dequeker J. The inverserelationship between osteoporosis and osteoarthitis. Adv Exp MedBiol 1999; 455: 419-422.
Turner CH. Toward a mathmaticaldescription of bone biology the principle of cellular accomodation.Calcif Tissue Int 1999; 65: 466-471.
Abarams SA. Using stableisotopes to assess moneral absorption and utilization by children.Am J Clin Nutr 1999; 70: 955-964.
Srivasasta T, Alon US.Bisphosphonates: from grandparents to grandchildren. Clin Pediatr1999; 38: 687-702.
Kanis JA. Vitamin D analogs:from renal bone disease to osteoporosis. Kidney Int 1999; 56(Supp): S77-S81.
Bogoch ER, Moran EL. Boneabnormalities in the surgical treatment of patients with rheumatoidarthitis. Clin Orthop 1999; 366: 8-21.
OTROS ARTÍCULOSDE INTERÉS
Cyteval C, Baron MP, Roux JO,et al. Acute osteoporotic vertebral colapse: Open study onpercutaneous injection of acrylic surgical cement in 20 patients.Am J Radiol 1999; 173: 1.685-1.690.
Serre CM, Farlay D, Delmas PD,Chenu C. Evidence for a dense and intimate innervation of the bonetissue, including glutamate-containing fibers. Bone 1999; 25:623-630.
Dennison E, Eastell R, FallCHD, et al. Determinats of bone loss in elderly men and women: aprospective population-based study. Osteoporosis Int 1999; 10:384-391.
Berntsen GKR, Tollan A, MagnusJH, et al. The Tromso Study: Artifacts in forearm bonedensitometry-prevalence and effects. Osteoporosis Int 1999; 10:425-432.
Toyras J, Kroger H, Jurvelin S.Bone properties as estimated by mineral density, ultrasoundattenuation and velocity. Bone 1999; 25: 725-732.
Kannus P, Parkkari J, PoutalaJ. Comparison of force attenuation properties of four different hipprotectors under simulated falling conditions in the elderly: anin vitro biochemical study. Bone 1999; 25:229-236.
Christiansen P, Steiniche T,Brixen K, et al. Primary hyperparathyroidism: Short-term changes inbone remodeling and bone mineral density followingparathyroidectomy. Bone 1999; 25: 137-244.
Yamamoto T, Kubo T, Hirasawa Y,et al. A clinicopathologic study of transient osteoporosis of thehip. Skeletal Radiol 1999; 28: 621-627.
Sugimoto T, Nakaoka D, Nasu M,et al. Effect of recombinant human growth hormone in elderlyosteoporotic women. Clin Endocrinol 1999; 51: 715-724.
Chiechi LM. Dietaryphytoestrogens in the prevention of longterm postmenoapusladiseases. Int J Gynecol Obtet 1999; 67: 39-40.
Leidig G, Pfeilschifter J,Penning N, et al. Severe osteoporosis in familial Hajdu-Cheneysyndrome: progression of acro-osteolysis and osteoporosis duringlong-term follow-up. J Bone Miner Res 1999; 14:2.036-2.041.
Armour KE, Van't Hof RJ,Grabowski PS, et al. Evidence for a pathogenic role of nitric oxidein inflamatory-induced osteoporosis. J Bone Miner Res 1999; 14:2.137-2.142.
Jamal SA, Ridout R, Chase C, etal. Bone mineral density testing and osteoporosis education improvelifestyle behaviors in premenopausal women: a prospective study. JBone Miner Res 1999; 14: 2.143-2.149.
Braatvedt GD, Joyce M, Evans M,et al. Bone mineral density on patients with treated Addisson'sdisease. Osteoporosis Int 1999; 10: 435-440.
Frost ML, Blake GM, FogelmansI. Contact quantitative ultrasound: an evaluation of precision,fracture discrimination, agerelated bone loss and applicability ofthe WHO criteria. Osteoporosis Int 1999; 10: 441-449.
Michaelsson K, Weiderpass E,Farahmand BY, et al. Differences in risk factors patterns betweencervical and trochanteric hip fractures. Osteoporosis Int 1999; 10:487-494.
Stehman-Breen CO, Gillen D,Gipson D. Prescription of hormone replacement therapy inpotsmenopausal women with renal failure. Kidney Int 1999; 56:2.243-2.247.
Parker CR, Freemont AJ,Blackwell PJ, et al. Cross-sectional acalysis of renaltransplantation osteoporosis. J Bone Miner Res 1999; 14:1.943-1.951.
Theodoru DJ, Theodoru SJ,Boutin RD, et al. Stress fracturs of the lateral metatarsal bonesin metatarsus adductus foot deformity: a previously unrecognizedassociation. Skeletal Radiol 1999; 28: 679-684.
Kang C, Speller R. The effectof region of interest selection on dual energy X-ray absorptionmeasurements of the calcaneous in 55 post-menoapusal women. Br JRadiol 1999; 72: 864-871.
Pluijm SM, Graafmants WC,Bouter LM, et al. Ultrasound measurements for the prediction ofosteoporotic fractures in old people. Osteoporosis Int 1999; 9:550-556.
Cuddihy MT, Gabriel SE,Crownson CS, et al. Forearm fracture as predictors of subsequentosteoporotic fractures. Osteoporosis Int 1999; 9:469-475.
Gnudi S, Ripamonti C,Gualtioeri G, et al. Geometry of proximal femur in the predictionof hip fracture in osteoporotic women. Br J Radiol 1999; 72:729-733.
Link TN, Majumdar S, Grampp S,et al. Imaging of trabecular bone structure in osteoporosis. EurRadiol 1999; 9: 1.781-1.788.
Brot C, Jorgensen NR, SorensenOH. The influence of smoking on vitamin D status and calciummetabolism. Eur J Clin Nutr 1999; 53: 920-926.
Hoerger TJ, Downs KE,Lakshmanan MC, et al. Helathcare use among US women aged 45 andolder: total costs and for selected postmenopausal health risks. JWomens Health Gend Based Med 1999; 8: 1077-1.089.